Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer’s Disease and Type 2 Diabetes-Reference-Cited by-同舟云学术

Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer’s Disease and Type 2 Diabetes

Published:2017-12-09 Issue:7 Volume:55 Page:6130-6144
ISSN:0893-7648
Container-title:Molecular Neurobiology
language:en
Short-container-title:Mol Neurobiol

Author:

Infante-Garcia Carmen,Ramos-Rodriguez Juan Jose,Hierro-Bujalance Carmen,Ortegon Esperanza,Pickett Eleanor,Jackson Rosemary,Hernandez-Pacho Fernando,Spires-Jones Tara,Garcia-Alloza Monica^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Neuroscience (miscellaneous),Cellular and Molecular Neuroscience,Neurology

Link

http://link.springer.com/article/10.1007/s12035-017-0825-7/fulltext.html

Reference66 articles.

1. Kalaria RN, Maestre GE, Arizaga R et al (2008) Alzheimer’s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol 7(9):812–826

2. Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1(1):a006189

3. Craft S (2009) The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol 66(3):300–305

4. Luchsinger JA, Tang MX, Shea S, Mayeux R (2004) Hyperinsulinemia and risk of Alzheimer disease. Neurology 63(7):1187–1192

5. Schrijvers EM, Witteman JC, Sijbrands EJ et al (2010) Insulin metabolism and the risk of Alzheimer disease: the Rotterdam study. Neurology 75(22):1982–1987

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association Between Type 2 Diabetes Mellitus and Alzheimer's Disease: Common Molecular Mechanism and Therapeutic Targets;Cell Biochemistry and Function;2024-09-03

2. Notoginsenoside R1, a novel natural PPARγ agonist, attenuates cognitive deficits in a mouse model of diabetic Alzheimer’s disease through enhancing GLUT4-dependent neuronal glucose uptake;2024-07-12

3. The role of antidiabetic drugs in the treatment of Alzheimer’s disease: systematic review;Problems of Endocrinology;2023-11-11

4. Rescue of neurogenesis and age‐associated cognitive decline in SAMP8 mouse: Role of transforming growth factor‐alpha;Aging Cell;2023-05-12

5. Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism;Frontiers in Pharmacology;2023-02-23